All Stories

  1. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  2. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  3. Vitamin D and Postoperative Recovery in Elderly Ribeirinhos—Riverside Amazon Communities with Femur Fractures
  4. Predictive modeling of depression and anxiety after myocardial infarction: a study on influential factors and heart rate variability
  5. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage
  6. Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  7. Photobiomodulation Therapy Reduces Oxidative Stress and Inflammation to Alleviate the Cardiotoxic Effects of Doxorubicin in Human Stem Cell-Derived Ventricular Cardiomyocytes
  8. Designing Personalized Multimodal Mnemonics With AI: A Medical Student’s Implementation Tutorial
  9. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  10. Human Pinealectomy Syndrome and the Impact of Melatonin Replacement Therapy: 1‐Cardiovascular Function
  11. Circadian system coordination: new perspectives beyond classical models
  12. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  13. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  14. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  15. Comparing and assessing physical activity and sedentary behaviour guidelines for different populations with and without chronic conditions and/or disabilities: a systematic review protocol
  16. High-frequency chest wall oscillation devices: An umbrella review and bibliometric analysis
  17. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  18. Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  19. From science to society: Exploring the nexus between obesity research and public awareness in Brazil
  20. Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020
  21. Comparison between melatonin versus melatonin and photobiomodulation versus photobiomodulation in the treatment of Alopecia X in German Spitz dogs: Clinical, randomized, double-blind, parallel, non-inferiority protocol
  22. The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019
  23. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  24. Burden of disease scenarios for 204 countries
  25. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  26. Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020
  27. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  28. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  29. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  30. Evidence for the druggability of aldosterone targets in heart failure: A bioinformatics and data science-driven decision-making approach
  31. High and low pitch sound stimuli effects on heart-brain coupling
  32. Global Burden of Cardiovascular Diseases and Risks, 1990-2022
  33. High and Low Pitch Sound Stimuli Effects on Heart-Brain Coupling
  34. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  35. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  36. Determinants of cervical spine disorders in military pilots: a systematic review
  37. The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study
  38. Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the Global Burden of Disease Study 2019
  39. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
  40. Sexual Dimorphism in the Expression of Cardiac and Hippocampal Renin-Angiotensin and Kallikrein–Kinin Systems in Offspring from Mice Exposed to Alcohol during Gestation
  41. Multiplatform-Integrated Identification of Melatonin Targets for a Triad of Psychosocial-Sleep/Circadian-Cardiometabolic Disorders
  42. Quantitative cardiac autonomic outcomes of hydrotherapy in women during the first stage of labor
  43. Editorial: Methods and applications in integrative physiology
  44. “Involve Me and I Learn”: Active Learning in a Hybrid Medical Biochemistry First Year Course on an American-Style MD Program in the UAE
  45. Burnout and Cardiovascular Risk in Healthcare Professionals During the COVID-19 Pandemic
  46. Photobiomodulation therapy's effects on cardiac fibrosis activation after experimental myocardial infarction
  47. Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia
  48. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  49. Heart Rate Variability Indices as Possible Biomarkers for the Severity of Post-traumatic Stress Disorder Following Pregnancy Loss
  50. The validation of oxygen uptake efficiency slope in patients with stroke
  51. Using the Gensini score to estimate severity of STEMI, NSTEMI, unstable angina, and anginal syndrome
  52. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  53. Physicians’ Attitudes Toward Telemedicine Consultations During the COVID-19 Pandemic: Cross-sectional Study
  54. Cross-Cultural Adaptation, Reliability, and Validity of a Brazilian of Short Version of the Posttraumatic Diagnostic Scale
  55. Health and Well-Being of Athletes During the Coronavirus Pandemic: A Scoping Review
  56. Bang the gavel: animal experimentation on trial—an interdisciplinary mock trial at the school of health sciences
  57. Prevalence and Determinants of Immediate and Long-Term PTSD Consequences of Coronavirus-Related (CoV-1 and CoV-2) Pandemics among Healthcare Professionals: A Systematic Review and Meta-Analysis
  58. The action of aripiprazole and brexpiprazole at the receptor level in singultus
  59. Impact of COVID-19 Pandemic Burnout on Cardiovascular Risk in Healthcare Professionals Study Protocol: A Multicenter Exploratory Longitudinal Study
  60. The value of coronary computed tomography angiography in assessing the cardiac circulation of an outpatient-based population
  61. The efficacy of baroreflex activation therapy for heart failure
  62. Cardiovascular and Quality of Life Outcomes of a 3-Month Physical Exercise Program in Two Brazilian Communities
  63. Next-generation sequencing identifies a novel heterozygous I229T mutation on LMNA associated with familial cardiac conduction disease
  64. Cardiovascular and Quality of Life Outcomes of a 3-Month Physical Exercise Program in Two Brazilian Communities
  65. Melatonin Therapy Improves Cardiac Autonomic Modulation in Pinealectomized Patients
  66. Therapeutic Renin Inhibition in Diabetic Nephropathy—A Review of the Physiological Evidence
  67. What is the optimal duration of the TILT after administration of 0.4 mg nitroglycerin spray?
  68. Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use
  69. Clinical outcomes of discordant exercise electrocardiographic and echocardiographic findings compared with concordant findings in patients with chest pain and no history of coronary artery disease
  70. Physical Activity Levels in a Structured Physical Exercise Community Program in Elderly
  71. Association between gene variants and the recurrence of atrial fibrillation
  72. Integrative bioinformatics analysis of miRNA and mRNA expression profiles and identification of associated miRNA-mRNA network in aortic dissection
  73. The Syntaxin-1A gene single nucleotide polymorphism rs4717806 associates with the risk of ischemic heart disease
  74. Obesity and metabolic syndrome in children in Brazil
  75. Identification of insulin-regulated aminopeptidase (IRAP) in the rat pineal gland and the modulation of melatonin synthesis by angiotensin IV
  76. Intrapartum Fetal Heart Rate: A Possible Predictor of Neonatal Acidemia and APGAR Score
  77. Melatonin, mitochondria and hypertension
  78. Association between Carotid Intima Media Thickness and Heart Rate Variability in Adults at Increased Cardiovascular Risk
  79. Quantifying Effects of Pharmacological Blockers of Cardiac Autonomous Control Using Variability Parameters
  80. Angiotensin—Encyclopedia of Stress
  81. Hormonal Physiology of Childbearing, an Essential Framework for Maternal–Newborn Nursing
  82. ICU Blood Pressure Variability May Predict Nadir of Respiratory Depression After Coronary Artery Bypass Surgery
  83. Morlet wavelet transforms of heart rate variability for autonomic nervous system activity
  84. Successful Pregnancy Following Assisted Reproduction in Woman With Systemic Lupus Erythematosus and Hypertension
  85. Cardiac autonomic dysfunction in elderly women with myocardial infarction
  86. PP.LB01.19
  87. Development of a monitoring system for evaluation of the mental health program in the city of Santarém, State of Pará, Brazil
  88. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy
  89. Heart Rate Detrended Fluctuation Indexes as Estimate of Obstructive Sleep Apnea Severity
  90. Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention
  91. The Angiotensin-Melatonin Axis
  92. Brain RAS: Hypertension and Beyond
  93. Cardiovascular responses evoked by activation or blockade of GABAA receptors in the hypothalamic PVN are attenuated in transgenic rats with low brain angiotensinogen
  94. Differential diagnosis between experimental endophthalmitis and uveitis in vitreous with Raman spectroscopy and principal components analysis
  95. Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure
  96. Models of Hypertension and Blood Pressure Recording
  97. Antidiuretic Effects of the Endothelin Receptor Antagonist Avosentan
  98. Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes
  99. Local renin–angiotensin system and the brain—A continuous quest for knowledge
  100. Effect of SPP 301, an Endothelin Antagonist, on Intraocular Pressure in Glaucomatous Monkey Eyes
  101. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson’s disease
  102. Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function
  103. Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B1 receptors
  104. Baroreflex control of heart rate and renal sympathetic nerve activity in rats with low brain angiotensinogen
  105. Antidiuretic effects of endothelin B receptor antagonism
  106. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension
  107. Angiotensin*
  108. Angiotensin1
  109. Enhanced isoproterenol-induced cardiac hypertrophy in transgenic rats with low brain angiotensinogen
  110. Brain renin-angiotensin system
  111. Altered circadian rhythm reentrainment to light phase shifts in rats with low levels of brain angiotensinogen
  112. Role of the renal nerves in blood pressure in male and female SHR
  113. Altered renal response to acute volume expansion in transgenic rats harboring the human tissue kallikrein gene
  114. Genetic targeting of the brain renin-angiotensin system in transgenic rats: Impact on stress-induced renin release
  115. Differential regulation of central vasopressin receptors in transgenic rats with low brain angiotensinogen
  116. Expression of an angiotensin-(1–7)-producing fusion protein produces cardioprotective effects in rats
  117. CIRCADIAN REGULATION OF ANGIOTENSINOGEN IN KIDNEY - EFFECT OF ANGIOTENSIN II
  118. Androgen receptor independent cardiovascular action of the antiandrogen flutamide
  119. Expression of smooth muscle MyHC B in blood vessels of hypertrophied heart in experimentally hypertensive rats
  120. Brain Renin-Angiotensin System
  121. Abolition of End-Organ Damage by Antiandrogen Treatment in Female Hypertensive Transgenic Rats
  122. Abolition of Hypertension-Induced End-Organ Damage by Androgen Receptor Blockade in Transgenic Rats Harboring the Mouse Ren-2 Gene
  123. Differential effects of angiotensin II and angiotensin-(1-7) at the nucleus tractus solitarii of transgenic rats with low brain angiotensinogen
  124. Locally synthesized angiotensin modulates pineal melatonin generation
  125. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research
  126. Alterations in Blood Pressure and Heart Rate Variability in Transgenic Rats With Low Brain Angiotensinogen
  127. Alterations of the renin-angiotensin system at the RVLM of transgenic rats with low brain angiotensinogen
  128. Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene
  129. ALTERED CARDIOVASCULAR FUNCTIONALITY OF THE RENIN-ANGIOTENSIN SYSTEM AT THE ROSTRAL VENTROLATERAL MEDULLA OF TRANSGENIC RATS WITH LOW BRAIN ANGIOTENSINOGEN
  130. Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats
  131. The Brain Renin-Angiotensin System Modulates Angiotensin II-Induced Hypertension and Cardiac Hypertrophy
  132. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen
  133. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system
  134. Local renin–angiotensin system in the pineal gland
  135. High levels of human chymase expression in the pineal and pituitary glands
  136. Mechanismus der Gewebe-Angiotensin-II-Bildung im Herzen und neue Befunde zum kardialen Angiotensin-II-System
  137. Effects of α-trinositol administered extra- and intracellularly (using liposomes) on rat aorta rings
  138. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction
  139. Effects of liposome-entrapped platelet-activating factor in the isolated rat trachea